Capecitabine is widely used in the management of metastatic breast cancer; however, drug delivery is limited by gastrointestinal and other toxicity. We employed mathematical modeling to rationally ...

Capecitabine Medication Information. Discover comprehensive details about Capecitabine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take ...

Capecitabine is an oral fluoropyrimidine prodrug that is selectively converted within cancer cells to the active drug 5-fluorouracil. Clinical trials have indicated that capecitabine is a safe and ...

Bridgewater et al 1 recently provided an update on the BILCAP trial that led capecitabine to become the recommended adjuvant chemotherapy for resected biliary tract cancer (BTC). Indeed, as we and ...

In the United States, the most common pronunciation of the word February is “FEB-yoo-air-ee.” Both Merriam-Webster and American Heritage dictionaries consider the common pronunciation correct ...

Seventy-three eligible patients (median age, 73 years; range, 65 to 89 years) were enrolled. The first 30 patients received oral capecitabine 1,250 mg/m 2 twice daily on days 1 to 14 every 21 days.

Capecitabine has a UK marketing authorisation for the first-line treatment of advanced gastric cancer in combination with a platinum-based regimen. 2.2 According to the summary of product ...

Online pronunciation training from the Goethe Institute can support you on your journey to speaking German better. During the training, you will work on the most important issues in German phonetics ...

The median survival was 11.2 months among the patients treated with epirubicin, oxaliplatin, and capecitabine (EOC [called EOX in the 2008 article]) and 9.9 months among the patients treated with ...

Capecitabine (Xeloda), an oral drug used to treat breast and colorectal cancers, has been associated with potentially fatal cutaneous reactions. The drug's manufacturer, Hoffmann-La Roche ...

Evidence-based recommendations on capecitabine and oxaliplatin in the adjuvant treatment of stage 3 (Dukes' C) colon cancer in adults.. Last reviewed: 4 July 2011 We checked this guidance and found ...